News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
175,716 Results
Type
Article (31968)
Company Profile (12)
Press Release (143736)
Multimedia
Podcasts (9)
Webinars (10)
Section
Business (52056)
Career Advice (365)
Deals (3234)
Drug Delivery (11)
Drug Development (23822)
Employer Resources (32)
FDA (3350)
Job Trends (3188)
News (80474)
Policy (4208)
Tag
Academia (2411)
Academic (1)
Accelerated approval (6)
Adcomms (9)
Allergies (35)
Alliances (10884)
ALS (47)
Alzheimer's disease (600)
Antibody-drug conjugate (ADC) (45)
Approvals (3447)
Artificial intelligence (112)
Autoimmune disease (28)
Automation (7)
Bankruptcy (17)
Best Places to Work (2670)
BIOSECURE Act (3)
Biosimilars (13)
Biotechnology (12)
Bladder cancer (36)
Brain cancer (26)
Breast cancer (180)
Cancer (1315)
Cardiovascular disease (90)
Career advice (343)
Career pathing (9)
CAR-T (77)
CDC (19)
Cell therapy (191)
Cervical cancer (9)
Clinical research (19520)
Collaboration (317)
Company closure (1)
Compensation (22)
Complete response letters (6)
COVID-19 (1198)
CRISPR (28)
C-suite (531)
Cystic fibrosis (32)
Data (2007)
Decentralized trials (1)
Denatured (6)
Depression (36)
Diabetes (119)
Diagnostics (1733)
Digital health (4)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (49)
Drug pricing (13)
Drug shortages (2)
Duchenne muscular dystrophy (40)
Earnings (6585)
Editorial (9)
Employer branding (2)
Employer resources (30)
Events (18477)
Executive appointments (620)
FDA (3908)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (388)
Gene editing (58)
Generative AI (5)
Gene therapy (132)
GLP-1 (164)
Government (991)
Guidances (24)
Healthcare (5053)
HIV (14)
Huntington's disease (6)
IgA nephropathy (24)
Immunology and inflammation (23)
Immuno-oncology (12)
Indications (19)
Infectious disease (1262)
Inflammatory bowel disease (53)
Inflation Reduction Act (1)
Influenza (36)
Intellectual property (36)
Interviews (41)
IPO (1461)
IRA (8)
Job creations (576)
Job search strategy (317)
JPM (4)
Kidney cancer (7)
Labor market (16)
Layoffs (38)
Leadership (6)
Legal (689)
Liver cancer (27)
Longevity (2)
Lung cancer (148)
Lymphoma (120)
Machine learning (10)
Management (9)
Manufacturing (94)
MASH (59)
Medical device (3119)
Medtech (3129)
Mergers & acquisitions (1862)
Metabolic disorders (248)
Multiple sclerosis (37)
NASH (5)
Neurodegenerative disease (91)
Neuropsychiatric disorders (11)
Neuroscience (914)
Neurotech (1)
NextGen: Class of 2026 (1799)
Non-profit (1718)
Now hiring (6)
Obesity (64)
Opinion (37)
Ovarian cancer (62)
Pain (40)
Pancreatic cancer (71)
Parkinson's disease (84)
Partnered (6)
Patents (68)
Patient recruitment (131)
Peanut (14)
People (33271)
Phase 1 (6170)
Phase 2 (8938)
Phase 3 (5978)
Pipeline (873)
Policy (53)
Postmarket research (955)
Preclinical (3151)
Press Release (25)
Prostate cancer (68)
Psychedelics (10)
Radiopharmaceuticals (75)
Rare diseases (173)
Real estate (1289)
Recruiting (16)
Regulatory (3355)
Reports (4)
Research institute (1380)
Resumes & cover letters (23)
Rett syndrome (4)
RNA editing (3)
RSV (5)
Schizophrenia (29)
Series A (59)
Series B (31)
Sickle cell disease (27)
Spinal muscular atrophy (43)
Sponsored (7)
Startups (1117)
Stomach cancer (1)
Supply chain (1)
Tariffs (7)
The Weekly (3)
Vaccines (277)
Venture capital (12)
Weight loss (37)
Women's health (20)
Worklife (2)
Date
Last 7 days (96)
Last 30 days (393)
Last 365 days (6179)
2026 (529)
2025 (6300)
2024 (7452)
2023 (9227)
2022 (11488)
2021 (13226)
2020 (12767)
2019 (12130)
2018 (9004)
2017 (8690)
2016 (8880)
2015 (10208)
2014 (7798)
2013 (7575)
2012 (7542)
2011 (7544)
2010 (6762)
Location
Africa (264)
Alabama (15)
Alaska (3)
Arizona (53)
Arkansas (6)
Asia (10711)
Australia (2668)
California (2352)
Canada (663)
China (244)
Colorado (100)
Connecticut (89)
Delaware (61)
Europe (28442)
Florida (297)
Georgia (83)
Idaho (13)
Illinois (183)
India (6)
Indiana (92)
Iowa (9)
Japan (107)
Kansas (19)
Kentucky (6)
Louisiana (7)
Maine (16)
Maryland (265)
Massachusetts (1575)
Michigan (52)
Minnesota (110)
Mississippi (4)
Missouri (36)
Montana (6)
Nebraska (5)
Nevada (20)
New Hampshire (12)
New Jersey (642)
New Mexico (8)
New York (657)
North Carolina (365)
North Dakota (3)
Northern California (1223)
Ohio (99)
Oklahoma (8)
Oregon (9)
Pennsylvania (448)
Puerto Rico (4)
Rhode Island (15)
South America (290)
South Carolina (11)
Southern California (866)
Tennessee (46)
Texas (388)
United States (8246)
Utah (71)
Virginia (56)
Washington D.C. (20)
Washington State (201)
West Virginia (2)
Wisconsin (26)
175,716 Results for "temple university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BetterWay Launches GLP-1 Blood Testing Panel at Retail Locations in Austin and Temple
January 30, 2026
·
2 min read
Business
Temple Street Biotech Initiates Groundbreaking Therapeutic Antibody for Alzheimer’s Disease
Temple Street Biotech is proud to announce the initiation of a pioneering therapeutic antibody targeting prion protein for the treatment of Alzheimer’s disease.
May 21, 2024
·
2 min read
Policy
JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval
Allergan Aesthetics, an AbbVie company, announced the U.S. FDA approval of JUVÉDERM® VOLUMA® XC for injection in the temple region to improve moderate to severe temple hollowing in adults over the age of 21.
March 5, 2024
·
10 min read
Temple Health Joins U.S. Study of Artificial Intelligence Diagnostic System for DVT Detection
Temple Health is partnering with ThinkSono, a UK-based AI company, to study a new artificial intelligence -powered ultrasound technology that enables more rapid and portable diagnosis of deep vein thrombosis.
February 13, 2024
·
2 min read
Three Medical Journals Investigate Temple University for Potential Data Manipulation
Three medical journals have launched investigations into publications by researchers at Temple University to determine if there was data manipulation.
September 14, 2022
·
4 min read
·
Mark Terry
Pharm Country
Temple University Hospital Adopts Masimo Centroid™
Masimo and Temple Health announced that Temple University Hospital, a 722-bed academic medical center located in Philadelphia, is expanding its use of Masimo technologies with Centroid™, an advanced wireless patient position, orientation, activity, and respiration rate sensor, at 100 beds across its ICU units.
February 7, 2022
·
13 min read
Press Releases
Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway
Session led by neurosurgeon Dr. Fraser Henderson and Hemostemix CEO Thomas Smeenk for the University of Florida’s Department of Surgery, Division of Vascular Surgery & Endovascular Therapy (Gainesville)
November 13, 2025
·
10 min read
Press Releases
University of Phoenix appoints Sheila Babendir as Dean of the College of Social and Behavioral Sciences
January 21, 2026
·
3 min read
Genetown
Temple Therapeutics Reveals Breakthrough Findings on Ovarian Cancer at AACR 2023
Temple Therapeutics presented new in vitro and in vivo data on TTX335o, the first drug candidate from the company’s platform that won the Eurostar Eureka peer-reviewed grant process in 2019 for ovarian cancer.
May 8, 2023
·
6 min read
Press Releases
Tolmar Opens Northern Illinois Laboratory at Rosalind Franklin University’s Innovation and Research Park
December 16, 2025
·
1 min read
1 of 17,572
Next
